Medigus to Present at the 27th Annual ROTH Conference

CEO Chris Rowland Scheduled to Present on March 11, 2015 at 10:00 a.m. PDT


OMER, Israel, March 6, 2015 (GLOBE NEWSWIRE) -- Medigus Ltd. (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced today that Chris Rowland Chief Executive Officer, will present at the 27th Annual ROTH Conference at 10:00 a.m. PDT, on March 11, 2015, Track 3: The Promenade. The conference will be held on March 9-11, 2015 at the Ritz Carlton, 1 Ritz Carlton Drive, Dana Point, California.

A live webcast of the presentation will be available to the public at: http://wsw.com/webcast/roth29/mdgs.ta. The webcast will be archived for 90 days following the live presentation. Medigus management will be available during the conference March 9-11 for one-on-one meetings.  Please contact your Roth representative or Miri Segal at msegal@ms-ir.com, to schedule a meeting.

About the 27th Annual ROTH Conference

This conference is one of the largest of its kind in the U.S. Following the success of previous years' events, the ROTH Conference, with close to 500 participating companies and over 3,000 attendees, will feature presentations from hundreds of public and private companies in a variety of sectors including Business Services, Cleantech & Solar, Consumer, Industrial Growth, Healthcare, Resources, Retail & E-Commerce and Technology & Media. ROTH combines company presentations, Q&A sessions, expert panels and management one-on-one meetings to provide institutional clients with extensive interaction with senior management to gain in-depth insights into each company. This conference is by invitation only. For more information, please contact conference@roth.com or your ROTH representative at (800) 933-6830.

About Medigus

Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions. Medigus is a pioneer developer of a unique proprietary endoscopic device, the MUSE(TM) system, to treat gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world. As an expert in micro-endoscopic devices, Medigus has developed a range of micro CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) video cameras, including micro ScoutCam(TM) 1.2, which to the best of the company's knowledge, is the smallest in the world. These innovative cameras are suitable for both medical and industrial applications. The MUSE system incorporates Medigus' revolutionary micro ScoutCam technology. Based on its proprietary technologies, Medigus designs and manufactures endoscopy and micro camera systems for partner companies, including major players in the medical and industrial fields. The company is committed to providing integrated solutions to meet all of its customer's imaging needs. Medigus is traded on the TASE (Tel-Aviv Stock Exchange). To learn more about the company's advanced technology, please visit www.medigus.com or www.microscoutcam.com.

INVESTOR RELATIONS CONTACT:
Miri Segal-Scharia
Hayden/MS-IR LLC
917-607-8654
msegal@ms-ir.com

MEDIA CONTACT:
Chantal Beaudry/ Carrie Yamond
Lazar Partners Ltd.
212-867-1762
cbeaudry@lazarpartners.com 
cyamond@lazarpartners.com

HUG#1900189